Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

Japan improved its regulation of regenerative medicine to ensure safety and prevent unproven treatments.

In 2011, hair restoration was a specialized field in plastic surgery, using techniques like "Ultrarefined follicular unit hair transplantation" to minimize scarring and promote hair growth, with future treatments like stem cell therapy and hair cloning still being tested.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

PRX102 is essential for rice root hair growth by helping transport substances to the tips.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

A new treatment using probiotic microneedles shows promise for promoting hair growth and reducing inflammation in androgenetic alopecia.

Spironolactone is effective for treating female hair loss, with new treatments like clascoterone showing promise.

New treatments for androgenetic alopecia show promise but need more research for validation.

These new skin treatments are safer and more effective with minimal side effects.

Combining microneedling with drugs and stem cells shows promise for improving hair growth in androgenetic alopecia.

Breezula® may be more effective than Minoxidil in promoting hair growth by reducing a hair growth inhibitor.

Hormonal therapies effectively treat acne and improve quality of life.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Spironolactone and clascoterone are promising acne treatments with fewer side effects.

Different types of hair loss have unique cellular changes, suggesting new treatment targets.

Clascoterone cream could be used for other skin conditions affected by hormones.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

New acne treatments like clascoterone and minocycline foam are effective, and using antibiotics carefully is important to avoid resistance.

Clinics using lasers should have trained laser safety supervisors to reduce accidents and possibly lower insurance costs.

Somatostatin helps hair follicles suppress immune responses, which might aid in treating certain hair loss conditions.